Vivek Subbiah: An overview of AI methods designed to detect cancer early – OncoDaily
Vivek Subbiah: An overview of AI methods designed to detect cancer early / AI, Amalie Dahl Haue, artificial intelligence, cancer, Davide Placido, Jessica Xin
Related Articles
Steward Health a cautionary tale in private equity’s push into health care
An investigation into Steward Health Care reveals a cautionary tale about the role of private equity in American health care and the corporate push for…
Texas teen accused of poisoning show goat of classmate she believed cheated
The 17-year-old allegedly admitted to police that she poisoned the goat because its owner was “a cheater” and she “doesn’t like cheaters,” the affidavit said.
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer | NEJM
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after…
Lunatic accused of shoving commuter into path of NYC subway charged…
Kamel Hawkins was charged with attempted murder. The lunatic accused of randomly shoving a Big Apple straphanger onto Manhattan subway tracks Tuesday afternoon was charged…
Man pushed in front of New York City subway train injured but alive, police say
The incident occurred in the heart of Manhattan and a man has been taken into custody, but charges are yet to be filed
This is some of what we must do to reform our dysfunctional healthcare system | Bernie Sanders
We are the wealthiest nation on Earth. There is no rational reason as to why we are not the healthiest nation on Earth
How soaring fees for private care are deepening England’s dentistry crisis
Ever growing numbers of people find themselves unable to get NHS treatment or pay for the alternative
UK patients unable to get dental care after ‘eye-watering’ rise in private fees
Exclusive: warning that lack of NHS dentists and soaring cost of private work puts essential care out of reach for many
Pitfalls of FDA-approved germline cancer predisposition tests
BUFFALO, NY – December 30, 2024 – A new editorial was published in Oncotarget’s Volume 15 on December 24, 2024, titled “Pitfalls and perils from FDA-approved germ-line cancer predisposition…
Potential dangers of direct-to-consumer genetic test for cancer risk
A new editorial was published in Oncotarget’s Volume 15 on December 24, 2024, titled “Pitfalls and perils from FDA-approved germ-line cancer predisposition tests.”